Rolf H. Henel, Director at SCICLONE PHARMACEUTICALS INC (SCLN), bought 9,400 shares at $2.27 ($21K) on 2007-12-28, disclosed to the SEC on 2008-01-02.
Open-market purchase of $21k SCLN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.26 | 300 | $678 | 3.2% |
| 2 | $2.27 | 9,100 | $21K | 96.8% |
| Total | $2.27 avg | 9,400 | $21K | 100% |
| Filing → |